Castle Creek Arbitrage, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 33 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Castle Creek Arbitrage, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$2,048,000
-27.7%
2,178,0000.0%0.70%
+4.6%
Q3 2018$2,834,000
-34.9%
2,178,000
-33.0%
0.67%
+44.3%
Q2 2018$4,351,000
-7.9%
3,250,000
-18.8%
0.47%
+35.0%
Q1 2018$4,725,000
+1.5%
4,000,0000.0%0.35%
-8.7%
Q4 2017$4,654,000
-2.3%
4,000,0000.0%0.38%
-20.7%
Q3 2017$4,762,000
-11.2%
4,000,0000.0%0.48%
-16.9%
Q2 2017$5,361,000
-52.2%
4,000,000
-55.6%
0.58%
-46.6%
Q1 2017$11,227,000
+8.4%
9,000,0000.0%1.08%
+9.1%
Q4 2016$10,358,000
-3.7%
9,000,0000.0%0.99%
-10.2%
Q3 2016$10,753,0009,000,0001.10%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Context Capital Management, LLC 1,000,000$1,164,0000.58%
CSS LLC/IL 7,044,000$8,236,0000.46%
WOLVERINE ASSET MANAGEMENT LLC 33,392,000$39,039,0000.45%
DeepCurrents Investment Group LLC 5,056,000$5,872,0000.26%
SSI INVESTMENT MANAGEMENT LLC 3,175,000$3,696,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 5,000,000$5,850,0000.17%
LINDEN ADVISORS LP 10,269,000$12,015,0000.14%
TENOR CAPITAL MANAGEMENT Co., L.P. 1,817,000$2,126,0000.11%
HBK INVESTMENTS L P 10,116,000$11,822,0000.11%
LAZARD ASSET MANAGEMENT LLC 16,000,000$18,783,0000.03%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders